Ferrara, Italy

Riccardo Baruchello

This inventor holds 1 USPTO granted patent. Top assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.. Active years: 2013.


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Riccardo Baruchello: Innovator in Antitumoural Compounds

Introduction

Riccardo Baruchello is a notable inventor based in Ferrara, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with antitumoural activities. His work focuses on innovative solutions to combat cancer and other diseases.

Latest Patents

Baruchello holds a patent for "Aryl isoxazole compounds with antitumoural activities." This invention relates to formula I compounds that exhibit antitumoural properties by targeting the molecular chaperone heat shock protein 90 (Hsp90). The patent outlines the use of these compounds in medicine, specifically for cancer treatment and other diseases responsive to Hsp90 inhibition. He has 1 patent registered under his name.

Career Highlights

Riccardo Baruchello is associated with Sigma-Tau Industrie Farmaceutiche Riunite S.p.a., where he has been instrumental in advancing pharmaceutical research. His expertise in the field has led to the development of innovative therapeutic solutions.

Collaborations

Throughout his career, Baruchello has collaborated with esteemed colleagues, including Daniele Simoni and Giuseppe Giannini. These partnerships have fostered a collaborative environment that enhances research and development efforts.

Conclusion

Riccardo Baruchello's contributions to the field of antitumoural compounds highlight his commitment to advancing medical science. His innovative work continues to pave the way for new treatments in the fight against cancer and other diseases.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…